z-logo
open-access-imgOpen Access
The effect of interleukin (IL)‐21 and CD4 + CD25 ++ T cells on cytokine production of CD4 + responder T cells in patients with myasthenia gravis
Author(s) -
AlahgholiHajibehzad M.,
Durmuş H.,
Aysal F.,
GülşenParman Y.,
Oflazer P.,
Deymeer F.,
SaruhanDireskeneli G.
Publication year - 2017
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.13006
Subject(s) - cytokine , myasthenia gravis , immunology , il 2 receptor , interleukin , interleukin 2 , endocrinology , biology , medicine , t cell , immune system
Summary Impairment of the suppressive function of regulatory T (T reg ) cells has been reported in myasthenia gravis (MG). In this study, cytokine‐related mechanisms that may lead to the defect of T reg were investigated in patients with anti‐acetylcholine receptor antibody‐positive MG (AChR + MG). Proliferation and cytokine production of responder T (T resp ) cells in response to polyclonal activation were measured in a suppression assay. The effect of interleukin (IL)‐21 on suppression was evaluated in vitro in co‐culture. IL‐21 increased the proliferation of T resp cells in T resp /T reg co‐cultures. T resp cells from patients with MG secreted significantly lower levels of IL‐2. In patients with MG, IL‐2 levels did not change with the addition of T reg to cultures, whereas it decreased significantly in controls. In T resp /T reg co‐cultures, IL‐4, IL‐6 and IL‐10 production increased in the presence of T reg in patients. Interferon (IFN)‐γ was decreased, whereas IL‐17A was increased in both patient and control groups. IL‐21 inhibited the secretion of IL‐4 in MG and healthy controls (HC), and IL‐17A in HC only. The results demonstrated that IL‐21 enhances the proliferation of T resp cells in the presence of T reg . An effect of IL‐21 mainly on T resp cells through IL‐2 is implicated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom